Matthias Wirth

19PUBLICATIONS
90CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsCell development, proliferation and deathPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 12, 2026
Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam.

|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

|Aug 06, 2025
Integrated real-time imaging of executioner caspase dynamics, apoptosis-induced proliferation, and immunogenic cell death using a stable fluorescent reporter platform.

Selen Selcen, Lena Wieland, Tiago De Oliveira

|Jun 04, 2024
A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic Cancer.

Matthias Wirth, Günter Schneider

|Dec 08, 2023
Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis.

Judith Dönig, Hannah Mende, Jimena Davila Gallesio

|Jul 29, 2023
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor.

Ramy Ashry, Al-Hassan M Mustafa, Kristin Hausmann

Pageof 4

Frequent Collaborators

11 joint publications

Ulrich Keller

5 joint publications

Günter Schneider

5 joint publications

Stefan Habringer

3 joint publications

Francis Baumgartner